Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic review.

Jelicic, Jelena; Larsen, Thomas Stauffer; Andjelic, Bosko; Juul-Jensen, Karen; Bukumiric, Zoran

Jelicic, Jelena; Larsen, Thomas Stauffer; Andjelic, Bosko; Juul-Jensen, Karen; Bukumiric, Zoran.

Afiliação

Jelicic J; Department of Hematology, Sygehus Lillebaelt, Vejle, Denmark; Department of Hematology, Odense University Hospital, Odense, Denmark. Electronic address: jelena.jelicic@rsyd.dk.
Larsen TS; Department of Hematology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Andjelic B; Department of Haematology, Blackpool Victoria Hospital, Lancashire Haematology Centre, Blackpool, United Kingdom.
Juul-Jensen K; Department of Hematology, Odense University Hospital, Odense, Denmark.
Bukumiric Z; Department of Statistics, Faculty of Medicine, University of Belgrade, Serbia.

Crit Rev Oncol Hematol ; 196: 104293, 2024 Apr.

Article em En | MEDLINE | ID: mdl-38346460

Assuntos

Linfoma Difuso de Grandes Células B; Nomogramas; Linfoma Difuso de Grandes Células B/diagnóstico; Linfoma Difuso de Grandes Células B/genética; Linfoma Difuso de Grandes Células B/patologia; Humanos; Prognóstico; Medição de Risco/métodos

Palavras-chave

Diffuse large B cell lymphoma; Gene-expression signature; Nomogram; Prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Nomogramas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google